Physician
Colorado West Healthcare System
Colorado West Healthcare System was paid $12.75M by Medicaid between Jan 2018 and Dec 2024, across 158 billing codes. Its largest line is 99284, emergency room visit (serious) — 26% of everything it billed.
33Billing provider infoCOLORADO WEST HEALTHCARE SYSTEM
GRAND JUNCTION, CO 81505
GRAND JUNCTION, CO 81505
33aNPI1497723407assigned 03/08/2006
33bProvider typeFamily Medicine Physician
28Total paid$12.75M
24GClaims293,033
24DCodes billed158
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Colorado
Rank by total paid#1 of 532
Median peer was paid$35K
This provider vs. median369×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official THOMAS, CHRISTIAN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 50,548 | $1.38M | |
| 2019 | 40,657 | $1.39M | |
| 2020 | 30,729 | $1.15M | |
| 2021 | 34,503 | $1.23M | |
| 2022 | 38,452 | $1.55M | |
| 2023 | 56,468 | $3.51M | |
| 2024incomplete | 41,676 | $2.54M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 28,076 | 21,937 | $3.31M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 23,325 | 18,077 | $2.42M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 11,363 | 9,274 | $1.67M |
| 96361 | Intravenous infusion, hydration; each additional hour | 12% | 3,477 | 3,106 | $1.51M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.2% | 1,677 | 1,329 | $665K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.0% | 7,793 | 5,948 | $387K |
| 80053 | Comprehensive metabolic panel | 2.0% | 23,396 | 17,893 | $249K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.4% | 4,006 | 3,369 | $178K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.2% | 1,481 | 1,074 | $149K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 2,171 | 1,977 | $146K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.1% | 4,011 | 3,374 | $145K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 636 | 501 | $136K |
146 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 3,380 | $112K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 27,727 | $108K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,594 | $93K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,725 | $91K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 710 | $72K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,373 | $64K |
| 97802 | <1% | 527 | $58K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 247 | $54K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,803 | $51K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,277 | $50K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,434 | $44K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,400 | $44K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 525 | $33K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,363 | $33K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 81 | $32K |
| 97804 | <1% | 339 | $30K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 13 | $30K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,664 | $28K |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,157 | $28K |
| 86780 | <1% | 1,239 | $28K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 740 | $28K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 7,909 | $23K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 3,856 | $23K |
| 88142 | <1% | 956 | $22K | |
| 80061 | Lipid panel | <1% | 1,622 | $21K |
| 86703 | <1% | 1,186 | $19K | |
| 87081 | <1% | 842 | $19K | |
| 83605 | <1% | 1,457 | $18K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,076 | $18K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 457 | $17K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 65 | $17K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,931 | $16K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,437 | $16K |
| 96367 | <1% | 203 | $16K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 69 | $16K |
| 84484 | <1% | 1,131 | $16K | |
| 83690 | <1% | 4,855 | $15K | |
| 81001 | <1% | 4,877 | $14K | |
| 81025 | <1% | 3,243 | $14K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 835 | $12K |
| 87077 | <1% | 1,061 | $12K | |
| 86850 | <1% | 892 | $10K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 9,871 | $10K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 14 | $10K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,444 | $10K |
| 87186 | <1% | 1,059 | $10K | |
| 87653 | <1% | 238 | $10K | |
| 84439 | <1% | 1,045 | $10K | |
| 87340 | <1% | 645 | $9K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 2,070 | $9K |
| 81003 | <1% | 7,763 | $9K | |
| 85027 | <1% | 1,471 | $9K | |
| 83735 | <1% | 1,768 | $8K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,856 | $8K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 137 | $8K |
| 99223 | Prolong inpt eval add15 m | <1% | 59 | $8K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,378 | $8K |
| 87486 | <1% | 165 | $7K | |
| 73610 | <1% | 147 | $7K | |
| 73130 | <1% | 173 | $7K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 59 | $7K |
| 86140 | <1% | 558 | $7K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 165 | $7K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 204 | $6K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 36 | $6K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 418 | $6K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,069 | $6K |
| 86762 | <1% | 276 | $5K | |
| 97161 | <1% | 25 | $5K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 695 | $5K |
| 0240U | <1% | 43 | $4K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 200 | $4K |
| 74160 | <1% | 20 | $4K | |
| 87581 | <1% | 165 | $4K | |
| 73630 | <1% | 111 | $4K | |
| 86592 | <1% | 201 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,807 | $3K |
| 87070 | <1% | 276 | $3K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 52 | $3K |
| 88300 | <1% | 91 | $3K | |
| 86900 | <1% | 973 | $3K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,208 | $3K |
| 86803 | <1% | 258 | $3K | |
| 86901 | <1% | 971 | $3K | |
| 80306 | <1% | 295 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 154 | $3K |
| 73562 | <1% | 45 | $2K | |
| 82728 | <1% | 141 | $2K | |
| 97165 | <1% | 15 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 165 | $2K |
| J3490 | Unclassified drugs | <1% | 110 | $2K |
| 83550 | <1% | 189 | $2K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 13 | $2K |
| 85610 | <1% | 548 | $2K | |
| 76830 | Ultrasound, transvaginal | <1% | 12 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 36 | $1K |
| 83540 | <1% | 163 | $1K | |
| 85652 | <1% | 452 | $1K | |
| 84703 | <1% | 155 | $1K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 14 | $1K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 32 | $1K |
| 99460 | <1% | 12 | $1K | |
| 84481 | <1% | 167 | $1K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 127 | $1K |
| 87210 | <1% | 77 | $900.60 | |
| 87430 | <1% | 329 | $847.91 | |
| 83880 | <1% | 44 | $836.23 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,497 | $773.79 |
| 36591 | <1% | 58 | $757.33 | |
| 73030 | <1% | 28 | $716.75 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 12 | $685.32 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 527 | $667.30 |
| 82565 | <1% | 146 | $648.68 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 24 | $619.55 |
| 82947 | <1% | 145 | $612.41 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 13 | $474.40 |
| 94060 | <1% | 12 | $470.80 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 500 | $396.81 |
| 84702 | <1% | 37 | $328.22 | |
| 94729 | <1% | 12 | $305.39 | |
| 80320 | <1% | 18 | $281.56 | |
| 82150 | <1% | 37 | $250.50 | |
| 84145 | <1% | 75 | $235.40 | |
| 94726 | <1% | 12 | $235.40 | |
| 82948 | <1% | 85 | $219.06 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 400 | $97.54 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 139 | $90.94 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 45 | $46.96 |
| 88342 | <1% | 13 | $45.58 | |
| 84450 | <1% | 27 | $43.92 | |
| 84460 | <1% | 27 | $32.11 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 46 | $18.71 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 1,236 | $14.04 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 71 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 643 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 613 | $0.00 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 4,720 | $0.00 |
| A9270 | Non-covered item or service | 0% | 397 | $0.00 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 0% | 413 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 302 | $0.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 0% | 12 | $0.00 |
| 85730 | 0% | 31 | $0.00 | |
| A4217 | Sterile water/saline, 500 ml | 0% | 58 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 12 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 394 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHOMAS, CHRISTIAN (CEO/PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Community Medical Group, LLC | Grand Junction, CO | $2.85M |
| Community Medical Group, LLC | Grand Junction, CO | $1.82M |
| Community Medical Group, LLC | Grand Junction, CO | $979K |
| Colorado West Healthcare System | Grand Junction, CO | $626K |
| Community Medical Group, LLC | Grand Junction, CO | $374K |
| Community Medical Group, LLC | Grand Junction, CO | $318K |
| Community Medical Group | Grand Junction, CO | $96K |
| Community Medical Group, LLC | Fruita, CO | $85K |
| Colorado West Healthcare System | Grand Junction, CO | $84K |
| Community Medical Group | Grand Junction, CO | $75K |
| Community Medical Group, LLC | Grand Junction, CO | $74K |
| Community Medical Group, LLC | Grand Jct, CO | $62K |
| Community Medical Group, LLC | Grand Junction, CO | $50K |
| Community Medical Group, LLC | Grand Junction, CO | $44K |
| Community Medical Group, LLC | Grand Junction, CO | $33K |
| Community Medical Group, LLC | Grand Junction, CO | $25K |
| Community Medical Group, LLC | Grand Junction, CO | $25K |
| Grand Valley Orthopedics | Grand Junction, CO | $21K |
| Canyon View Asc, LLC | Grand Junction, CO | $15K |
| Community Medical Group, LLC | Palisade, CO | $15K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.